1. Asthma-like symptoms, atopy, and bronchial responsiveness in furniture workers. Issue 11 (November 1998) Authors: Talini, D; Monteverdi, A; Benvenuti, A; Petrozzino, M; Di Pede, F; Lemmi, M; Carletti, A; Macchioni, P; Serretti, N; Viegi, G; Paggiaro, P Journal: Occupational and environmental medicine Issue: Volume 55:Issue 11(1998) Page Start: 786 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P148 Once-daily tiotropium Respimat® add-on to at least ICS maintenance therapy reduces exacerbation risk in patients with uncontrolled symptomatic asthma. (12th November 2015) Authors: Halpin, D; Bateman, ED; Paggiaro, P; Bleecker, ER; Engel, M; Moroni-Zentgraf, P; Schmidt, H; Kerstjens, HAM Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. P149 Once-daily tiotropium Respimat® add-on to at least ICS in adult patients with symptomatic asthma: pooled safety analysis. (12th November 2015) Authors: Dusser, D; Buhl, R; Castro, M; Kerstjens, HAM; Paggiaro, P; Engel, M; Moroni-Zentgraf, P; Unseld, A; Bateman, ED Journal: Thorax Issue: Volume 70(2015)Supplement 3 Page Start: A151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P163 Tiotropium decreases the risk of exacerbations in patients with symptomatic asthma regardless of baseline characteristics including markers of allergic status. (14th November 2013) Authors: Halpin, DMG; Bateman, ED; Tashkin, DP; Engel, M; Dahl, R; Paggiaro, P; Beck, E; Vandewalker, M; Seibold, W; Moroni-Zentgraf, P; Schmidt, H; Kerstjens, HAM Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A149 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. P230 Symptomatic benefit of olodaterol QD delivered via Respimat® vs placebo and formoterol BID in patients with COPD: combined analysis from two 48-week studies. (14th November 2013) Authors: Koch, A; Paggiaro, P; Hamilton, A; Hart, L; Korducki, L; De Salvo, Mc; Pizzichini, E Journal: Thorax Issue: Volume 68(2013)Supplement 3 Page Start: A180 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. P231 Once-daily Tiotropium Respimat®: Safety And Tolerability Results From Five Phase Iii Trials In Adults With Symptomatic Asthma. (10th November 2014) Authors: Haughney, J; Vandewalker, M; Meltzer, E; Paggiaro, P; Engel, M; Unseld, A; Moroni-Zentgraf, P; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A178 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. P255 Once-daily Tiotropium Respimat® Add-on To At Least Ics Maintenance Therapy Reduces Exacerbation Risk In Patients With Uncontrolled Symptomatic Asthma. (10th November 2014) Authors: Halpin, DMG; Paggiaro, P; Bleecker, E; Engel, M; Moroni-Zentgraf, P; Schmidt, H; Kerstjens, HAM Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A189 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. P260 Tiotropium Respimat® Add-on To Inhaled Corticosteroids Improves Lung Function In Patients With Symptomatic Mild Asthma: Results From A Phase Iii Trial. (10th November 2014) Authors: Paggiaro, P; Halpin, DMG; Buhl, R; Engel, M; Zubek, VB; Blahova, Z; Moroni-Zentgraf, P; Pizzichini, E Journal: Thorax Issue: Volume 69(2014)Supplement 2 Page Start: A191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. S31 Dupilumab reduces severe exacerbations across baseline disease characteristics in patients with elevated baseline type 2 biomarkers: the LIBERTY ASTHMA QUEST study. (12th November 2019) Authors: Busse, WW; Muñoz, X; Casale, TB; Paggiaro, P; Castro, M; Tohda, Y; Rice, MS; Deniz, Y; Rowe, P; Amin, N; Teper, A Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A21 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. S49 Dupilumab improves lung function across baseline disease characteristics in patients with evidence of type 2 inflammation at baseline: the LIBERTY ASTHMA QUEST study. (12th November 2019) Authors: Paggiaro, P; Castro, M; Canonica, WG; Douglass, JA; Tohda, Y; Rice, MS; Deniz, Y; Rowe, P; Amin, N; Teper, A Journal: Thorax Issue: Volume 74(2019)Supplement 2 Page Start: A33 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗